News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BMW is a buy for a 180-day horizon, citing a strong product cycle, scaling EVs, and cost discipline.
  • MPLX offers a 7%+ distribution yield with mid-single-digit EBITDA growth potential and income cushioning downside.
  • Sandisk is a buy on AI infrastructure-driven revenue, high margins, and strong free cash flow after a pullback.
  • Antero Resources looks vulnerable; a mid-term short targets $32 from $39 if weather-driven gas strength fades.
  • X-Energy is a long-term buy for high-temperature reactor and TRISO fuel optionality, tied to milestones.
  • NVIDIA is a guidance-driven buy after upside guidance and AI revenue acceleration, with a $391 target.
  • Hold Tyra Biosciences ahead of the Sept 9 IR-NMIBC readout due to financing risk and a binary clinical event.

Latest Articles

EU Competition Watch Turns to Oracle Over Licensing Practices

EU Competition Watch Turns to Oracle Over Licensing Practices

EU competition authorities have their focus on the licensing practices of U.S. cloud software company Oracle, according to a person familiar with the matter. The European Commission is soliciting information from third parties to determine whether to pursue enforcement, in a probe comparable to one involving SAP that was resolved with concessions i…

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

aTyr Pharma provided an update indicating they expect a FDA response by mid-September 2026 regarding their submitted protocol for a planned global Phase 3 trial of efzofitimod in patients with moderate to severe pulmonary sarcoidosis. The trial aims to evaluate efficacy and safety over 54 weeks, with primary and secondary lung function endpoints, i…

United Community Banks, Inc. Announces Completion of Sale of Navitas Equipment Finance Business to Funds Managed by Wafra Inc.

United Community Banks, Inc. Announces Completion of Sale of Navitas Equipment Finance Business to Funds Managed by Wafra Inc.

United Community Banks, Inc. announced the completion of the sale of its Navitas equipment finance business to funds managed by Wafra Inc. for approximately $2 billion in cash, representing a 7% premium to the loan portfolio's par value. This transaction allows United Community Banks to concentrate on its core Southeastern relationship banking busi…

California Resources Corporation Completes Acquisition of Crimson

California Resources Corporation Completes Acquisition of Crimson

California Resources Corporation (NYSE: CRC) announced the completion of its $63 million all-cash acquisition of Crimson Midstream Holdings, LLC from CorEnergy Infrastructure Trust. Approved by the California Public Utilities Commission, this acquisition strengthens CRC's energy portfolio by adding midstream infrastructure to improve delivery effic…

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Braveheart Bio, a clinical-stage biopharmaceutical company specializing in treatments for hypertrophic cardiomyopathy and other cardiovascular diseases, announced its participation in the Cantor Global Healthcare Conference. The company's management will engage in a fireside chat to discuss their lead product candidate, BHB-1893, an oral small-mole…

Cellectis Announces Participation in Upcoming Investor Conferences

Cellectis Announces Participation in Upcoming Investor Conferences

Cellectis, a clinical-stage biotech company specializing in gene editing and CAR T-cell therapies, announced its participation in several upcoming healthcare investor conferences across the US and Europe. Management will engage with investors and present updates on the company's developments and strategic direction, continuing to promote its pionee…

STERIS to Present at the Morgan Stanley Healthcare Conference

STERIS to Present at the Morgan Stanley Healthcare Conference

STERIS plc, a global provider of healthcare and life science products focused on infection prevention, announced its participation in the Morgan Stanley Healthcare Conference where CEO Dan Carestio will present. The company highlighted the availability of a webcast and included a detailed cautionary statement regarding forward-looking statements an…

Xos Hub Surpasses One Gigawatt-Hour of Energy Delivered in the Field

Xos Hub Surpasses One Gigawatt-Hour of Energy Delivered in the Field

Xos, Inc. announced that its Xos Hub energy storage and charging system has surpassed one gigawatt-hour of cumulative energy delivered, demonstrating durability and reliability in continuous commercial operation since early 2025. This milestone supports the company's growth with expanded product versions, utility deployment orders, and entry into t…

Micron: The 2028 Overhang Is Losing Its Grip — A Tactical Long Setup

Micron: The 2028 Overhang Is Losing Its Grip — A Tactical Long Setup

Micron has rallied sharply in 2026, but the headline risk that memory demand will crater after large OEM procurement commitments in late 2028 looks increasingly priced in. With a $1.05T market cap, robust margins, and $26.2B in free cash flow last reported, the setup favors a long trade that captures continued AI and cloud memory absorption while m…

MYR Group Inc. to Attend Jefferies Renewables, Clean Energy, & Construction Conference in September

MYR Group Inc. to Attend Jefferies Renewables, Clean Energy, & Construction Conference in September

MYR Group Inc., a leading specialty electrical contractor serving the U.S. and Canadian markets, announced that its CEO and CFO will participate in the Jefferies Renewables, Clean Energy, & Construction investor conference virtually. The company offers services in electric utility infrastructure including transmission, distribution, clean energy pr…

Yatra Online, Inc. Board of Directors Unanimously Rejects Magna Holdings’ Unsolicited Partial Tender Offer

Yatra Online, Inc. Board of Directors Unanimously Rejects Magna Holdings’ Unsolicited Partial Tender Offer

Yatra Online, Inc.'s Board of Directors unanimously opposes Magna Holdings Ltd.'s unsolicited partial tender offer to acquire up to 31% of the company's shares at $1.10 per share, stating the offer substantially undervalues the company and presents significant risks to shareholders. The Board recommends shareholders reject the offer due to the unde…